Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Pharma
Bayer nabs 1st-in-class FDA nod for stroke med asundexian
The FDA has signed off on Bayer’s factor XIa inhibitor asundexian, ushering in one of the first major revolutions in stroke prevention in decades.
Fraiser Kansteiner
Nov 9, 2026 9:10pm
Pharma rebound puts Bayer split debate back on the table
Nov 3, 2026 11:27am
Bayer's Nubeqa eyes wider market after phase 3 win
Oct 24, 2026 8:30am
Melissa explains it all in menopause team up with Bayer
Oct 8, 2026 9:24am
Bayer doubles down on US with $2.2B Ohio manufacturing project
Oct 2, 2026 3:10pm
Bayer sells cancer drug Stivarga to Grünenthal for up to $431M
Sep 21, 2026 10:20am
